Approval · Notice of Compliance 28150 · 2022
PMS-CLARITHROMYCIN: Notice of Compliance 28150
Issued May 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28150
- Date
- May 13, 2022
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph. To convert the product monograph to 2020 format
- Canadian reference product
- BIAXIN BID (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-CLARITHROMYCIN | Not yet assigned | — |
Medicinal ingredients
- CLARITHROMYCIN 250 MG per TAB
- CLARITHROMYCIN 500 MG per TAB